BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28823671)

  • 1. Surgical Resection and Cellular Proliferation Index Predict Prognosis for Patients with Papillary Glioneuronal Tumor: Systematic Review and Pooled Analysis.
    Ahmed AK; Dawood HY; Gerard J; Smith TR
    World Neurosurg; 2017 Nov; 107():534-541. PubMed ID: 28823671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.
    Schlamann A; von Bueren AO; Hagel C; Zwiener I; Seidel C; Kortmann RD; Müller K
    PLoS One; 2014; 9(7):e101211. PubMed ID: 24991807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review.
    Weng JC; Li D; Wang L; Wu Z; Wang JM; Li GL; Jia W; Zhang LW; Zhang JT
    J Neurosurg; 2018 Oct; 131(3):695-705. PubMed ID: 30497189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary glioneuronal tumor with a high proliferative component and minigemistocytes in a child.
    Momota H; Fujii M; Tatematsu A; Shimoyama Y; Tsujiuchi T; Ohno M; Natsume A; Wakabayashi T
    Neuropathology; 2014 Oct; 34(5):484-90. PubMed ID: 24738632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
    Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
    J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary glioneuronal tumor--prognostic value of the extension of surgical resection.
    Pimentel J; Barroso C; Miguéns J; Firmo C; Antunes JL
    Clin Neuropathol; 2009; 28(4):287-94. PubMed ID: 19642508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary glioneuronal tumor with minigemistocytic components and increased proliferative activity.
    Ishizawa T; Komori T; Shibahara J; Ishizawa K; Adachi J; Nishikawa R; Matsutani M; Hirose T
    Hum Pathol; 2006 May; 37(5):627-30. PubMed ID: 16647962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive papillary glioneuronal tumor: case report and literature review.
    Newton HB; Dalton J; Ray-Chaudhury A; Gahbauer R; McGregor J
    Clin Neuropathol; 2008; 27(5):317-24. PubMed ID: 18808063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical papillary glioneuronal tumor.
    Vaquero J; Coca S
    J Neurooncol; 2007 Jul; 83(3):319-23. PubMed ID: 17285229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of surgical resection and tumor size predicts prognosis in granular cell tumor of the sellar region.
    Ahmed AK; Dawood HY; Penn DL; Smith TR
    Acta Neurochir (Wien); 2017 Nov; 159(11):2209-2216. PubMed ID: 28948361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences.
    Tomita T; Volk JM; Shen W; Pundy T
    Childs Nerv Syst; 2016 Oct; 32(10):1839-48. PubMed ID: 27659827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary glioneuronal tumor.
    Gelpi E; Preusser M; Czech T; Slavc I; Prayer D; Budka H
    Neuropathology; 2007 Oct; 27(5):468-73. PubMed ID: 18018482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary glioneuronal tumor. Case report and literature review.
    Celli P; Caroli E; Giangaspero F; Ferrante L
    J Neurooncol; 2006 Nov; 80(2):185-9. PubMed ID: 16703452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
    Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
    J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of Ki-67 in solid pseudopapillary tumor of the pancreas: Huashan experience and systematic review of the literature.
    Yang F; Yu X; Bao Y; Du Z; Jin C; Fu D
    Surgery; 2016 Apr; 159(4):1023-31. PubMed ID: 26619927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.
    Nagaishi M; Nobusawa S; Matsumura N; Kono F; Ishiuchi S; Abe T; Ebato M; Wang Y; Hyodo A; Yokoo H; Nakazato Y
    J Clin Neurosci; 2016 Jan; 23():73-75. PubMed ID: 26260115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary glioneuronal tumor--contribution to a new tumor entity and literature review.
    Guo SP; Zhang F; Li QL; Li Q; Wang WL; Li FF
    Clin Neuropathol; 2008; 27(2):72-7. PubMed ID: 18402385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
    Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
    Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.